Q3304812 (Q3304812): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in en: Setting new description) |
(Created claim: summary (P836): The aim is to develop suitable marketable products for the analysis of mutation status in patients with diseases of genetic origin that could be used as a certified reference material in diagnostic procedures., translated_summary) |
||||||||||||||
| Property / summary | |||||||||||||||
The aim is to develop suitable marketable products for the analysis of mutation status in patients with diseases of genetic origin that could be used as a certified reference material in diagnostic procedures. (English) | |||||||||||||||
| Property / summary: The aim is to develop suitable marketable products for the analysis of mutation status in patients with diseases of genetic origin that could be used as a certified reference material in diagnostic procedures. (English) / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / summary: The aim is to develop suitable marketable products for the analysis of mutation status in patients with diseases of genetic origin that could be used as a certified reference material in diagnostic procedures. (English) / qualifier | |||||||||||||||
point in time: 24 October 2021
| |||||||||||||||
Revision as of 17:47, 24 October 2021
Project Q3304812 in Germany
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | No label defined |
Project Q3304812 in Germany |
Statements
1,061,698.35 Euro
0 references
1,327,122.94 Euro
0 references
80.0 percent
0 references
1 December 2017
0 references
31 December 2021
0 references
SensID GmbH
0 references
17489 - Greifswald
0 references
Ziel ist es, geeignete marktfähige Produkte für die Analytik des Mutationsstatus bei Patienten mit Erkrankungen genetischen Ursprungs zu entwickeln, die bei diagnostischen Verfahren als zertifiziertes Referenzmaterial eingesetzt werden könnte. (German)
0 references
The aim is to develop suitable marketable products for the analysis of mutation status in patients with diseases of genetic origin that could be used as a certified reference material in diagnostic procedures. (English)
24 October 2021
0 references
Identifiers
DE_TEMPORARY_7597
0 references